SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,792,680 | -1.1% | 80,661 | -11.8% | 0.01% | -14.3% |
| Q1 2023 | $3,835,480 | +980.4% | 91,408 | +909.7% | 0.01% | +600.0% |
| Q3 2022 | $355,000 | -88.9% | 9,053 | -90.8% | 0.00% | -85.7% |
| Q2 2022 | $3,189,000 | +21.7% | 98,727 | +24.6% | 0.01% | +55.6% |
| Q1 2022 | $2,621,000 | +1184.8% | 79,208 | +1620.8% | 0.01% | +800.0% |
| Q3 2021 | $204,000 | +2.0% | 4,603 | +31.2% | 0.00% | 0.0% |
| Q2 2021 | $200,000 | -82.4% | 3,508 | -76.9% | 0.00% | -80.0% |
| Q1 2021 | $1,139,000 | -73.1% | 15,218 | -68.9% | 0.01% | -73.7% |
| Q4 2020 | $4,233,000 | -46.1% | 48,932 | -61.9% | 0.02% | -38.7% |
| Q3 2020 | $7,853,000 | +195.6% | 128,487 | +101.1% | 0.03% | +138.5% |
| Q2 2020 | $2,657,000 | +147.9% | 63,893 | +71.2% | 0.01% | +85.7% |
| Q1 2020 | $1,072,000 | -53.1% | 37,316 | +129.2% | 0.01% | -12.5% |
| Q3 2019 | $2,284,000 | +475.3% | 16,279 | +650.9% | 0.01% | +700.0% |
| Q2 2019 | $397,000 | -81.1% | 2,168 | -83.6% | 0.00% | -87.5% |
| Q1 2019 | $2,102,000 | -3.7% | 13,215 | -14.5% | 0.01% | 0.0% |
| Q3 2018 | $2,183,000 | +202.8% | 15,452 | +235.6% | 0.01% | +166.7% |
| Q2 2018 | $721,000 | +220.4% | 4,604 | +229.1% | 0.00% | +200.0% |
| Q1 2018 | $225,000 | – | 1,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |